Cytocast logo — REVOLUTIONIZING DRUG DISCOVERY AND PERSONALIZED MEDICINE THR...

Cytocast

REVOLUTIONIZING DRUG DISCOVERY AND PERSONALIZED MEDICINE THROUGH CELL SIMULATION

Founded 2019 Hungary Hungary 19 employees Pre Seed Total: $1.86M Biotechnology, Health Care +3

General Information

Company Name Cytocast
Founded Year 2019
Location Hungary Hungary +1
Employees 19
Industries Biotechnology, Health Care, Medical Devices +2
Funding Stage Pre Seed
Social

Get notified when Cytocast moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cytocast

Cytocast is a TechBio startup company founded in 2019, headquartered in Hungary. The company's slogan, "Safer and Smarter Drug Development - Transforming drug development and precision medicine with advanced cell simulation," reflects its mission to revolutionize drug development and precision medicine with its Cytocast Digital Twin platform. The platform integrates multi-omics data and advanced computational modeling to predict the effects of different drugs on cellular processes, enabling early-stage drug side effect predictions. Cytocast is at the forefront of advancing personalized medicine, moving towards tailored therapies with its advanced technologies. In May 2023, the company secured a €1.64M investment in a Pre-Seed Round from investors including Bonitas Venture Capital Fund, Zoiros Ventures, FastVentures, Futurmed, and KDT Holding. Cytocast's innovative approach and focus on patient well-being position it as a promising player in the Biotechnology, Health Care, Medical Devices, Pharmaceutical, and Clean Energy industries.

Taxonomy: bioinformatics, drug discovery, personalized treatment, Budapest, patient data, computer models, cellular health

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round •••••• 5
Investor
•••• ••••
15 May 2023
Pre Seed Round •••••• 1
Investor
01 Dec 2021
Non Equity Assistance •••••• - 01 Jan 2020

Cytocast Alternatives & Competitors

Cytocast vs

OPER TECHNOLOGY LIMITED is to develop and perfect an innovative technology in nanomaterial-based per...

2 employees
Biotechnology, Health Care
Cytocast vs

Communication Science, the makers of Care Kit—a revolutionary product designed for personal & profes...

Series Unknown
8 employees
Health Care, Pharmaceutical
Cytocast vs

Accelerating drug discovery and predicting the best cancer treatment for you!

Series A
19 employees
Biopharma, Biotechnology

FAQ About Cytocast

REVOLUTIONIZING DRUG DISCOVERY AND PERSONALIZED MEDICINE THROUGH CELL SIMULATION
Cytocast was founded in 2019.
Cytocast is headquartered in Hungary.
Cytocast operates in the following industries: Biotechnology, Health Care, Medical Devices, Pharmaceutical, Clean Energy.
Cytocast has approximately 19 employees.
Cytocast has completed 3 funding rounds, raising a total of $1.86M. The latest funding stage is Pre Seed.
Top alternatives and competitors to Cytocast include OPER Technology Limited, Communication Science, Inc., BioReperia, Celsius Therapeutics, Excelra. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cytocast and OPER Technology Limited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cytocast and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy